Lifileucel: all 24 studies that test it

Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue SarcomaRecruitingNCT07741877Phase 2
• PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced MelanomaNot yet recruitingNCT07700121Early Phase 1
• A Phase II Study of GC101 in NSCLCRecruitingNCT07560111Phase 2
• TIL Therapy in cSCC and MCCRecruitingNCT07288073Phase 2
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.RecruitingNCT06481592Phase 2
• A Phase Ib Study of GC101 in NSCLCRecruitingNCT06473961Phase 1
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver CancerRecruitingNCT06084299Phase 1
• Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver MetastasesNot yet recruitingNCT05903937Phase 1
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.RecruitingNCT05727904Phase 3
• A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or AngiosarcomaRecruitingNCT05607095Phase 1
• Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerRecruitingNCT04614103Phase 2
• Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid TumorsTerminatedNCT03991741Phase 1Results posted
• Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical CarcinomaTerminatedNCT03108495Phase 2Results posted
• Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & NeckCompletedNCT03083873Phase 2Results posted
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic MelanomaCompletedNCT02360579Phase 2Results posted
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced MelanomaActive, not recruitingNCT07288203Phase 2
• Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsTerminatedNCT06566092Phase 1
• Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable MelanomaWithdrawnNCT06190249Phase 1
• Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic MelanomaCompletedNCT06151847Phase 2
• A Study of LN-144 in People With Metastatic Melanoma to the BrainActive, not recruitingNCT05640193Phase 1
• Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma PatientsActive, not recruitingNCT05176470Phase 1
• Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver MetastasesCompletedNCT04812470Phase 1
• Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsTerminatedNCT03645928Phase 2
• Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung CancerWithdrawnNCT03419559Phase 2

← Lifileucel overview